PCSK9 and cardiovascular disorder: So-called statins (HMG-CoA reductase inhibitors) and proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors to reduce LDL-C by approximately half at maximum are used for the purpose of preventing arteriosclerotic diseases including cardiovascular disease (CVD) [3, 4].